Global Hematologic Malignancies Detection Market Research Report 2024(Status and Outlook)
Report Overview:
Hematological malignancy is a major disease that seriously endangers human health. With the invention and application of polymerase chain reaction, immunohistochemistry, next-generation sequencing and fluorescence in situ hybridization, its overall diagnostic level has been significantly improved.
The Global Hematologic Malignancies Detection Market Size was estimated at USD 2566.34 million in 2023 and is projected to reach USD 5813.28 million by 2029, exhibiting a CAGR of 14.60% during the forecast period.
This report provides a deep insight into the global Hematologic Malignancies Detection market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Hematologic Malignancies Detection Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Hematologic Malignancies Detection market in any manner.
Global Hematologic Malignancies Detection Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
ArcherDx
Bio-Rad Laboratories
sysmex
Invitae
NeoGenomics Laboratories
Abbott Laboratories
Cancer Genetics
Adaptive Biotechnologies Corporation
Asuragen
Invivoscribe
Nanjing Shihejiyin Technology
Annaroad Gene Technology
BGI Genomics
Market Segmentation (by Type)
Polymerase Chain Reaction
Immunochemistry
Next Generation Sequencing
Fluorescence in Situ Hybridization
Others
Market Segmentation (by Application)
Multiple Myeloma
Myelodysplastic Syndrome
Leukemia
Myeloproliferative Neoplasms
Lymphoma
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Hematologic Malignancies Detection Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Hematological malignancy is a major disease that seriously endangers human health. With the invention and application of polymerase chain reaction, immunohistochemistry, next-generation sequencing and fluorescence in situ hybridization, its overall diagnostic level has been significantly improved.
The Global Hematologic Malignancies Detection Market Size was estimated at USD 2566.34 million in 2023 and is projected to reach USD 5813.28 million by 2029, exhibiting a CAGR of 14.60% during the forecast period.
This report provides a deep insight into the global Hematologic Malignancies Detection market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Hematologic Malignancies Detection Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Hematologic Malignancies Detection market in any manner.
Global Hematologic Malignancies Detection Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
ArcherDx
Bio-Rad Laboratories
sysmex
Invitae
NeoGenomics Laboratories
Abbott Laboratories
Cancer Genetics
Adaptive Biotechnologies Corporation
Asuragen
Invivoscribe
Nanjing Shihejiyin Technology
Annaroad Gene Technology
BGI Genomics
Market Segmentation (by Type)
Polymerase Chain Reaction
Immunochemistry
Next Generation Sequencing
Fluorescence in Situ Hybridization
Others
Market Segmentation (by Application)
Multiple Myeloma
Myelodysplastic Syndrome
Leukemia
Myeloproliferative Neoplasms
Lymphoma
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Hematologic Malignancies Detection Market
- Overview of the regional outlook of the Hematologic Malignancies Detection Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Hematologic Malignancies Detection Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Hematologic Malignancies Detection
1.2 Key Market Segments
1.2.1 Hematologic Malignancies Detection Segment by Type
1.2.2 Hematologic Malignancies Detection Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 HEMATOLOGIC MALIGNANCIES DETECTION MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Hematologic Malignancies Detection Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Hematologic Malignancies Detection Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 HEMATOLOGIC MALIGNANCIES DETECTION MARKET COMPETITIVE LANDSCAPE
3.1 Global Hematologic Malignancies Detection Sales by Manufacturers (2019-2024)
3.2 Global Hematologic Malignancies Detection Revenue Market Share by Manufacturers (2019-2024)
3.3 Hematologic Malignancies Detection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Hematologic Malignancies Detection Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Hematologic Malignancies Detection Sales Sites, Area Served, Product Type
3.6 Hematologic Malignancies Detection Market Competitive Situation and Trends
3.6.1 Hematologic Malignancies Detection Market Concentration Rate
3.6.2 Global 5 and 10 Largest Hematologic Malignancies Detection Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 HEMATOLOGIC MALIGNANCIES DETECTION INDUSTRY CHAIN ANALYSIS
4.1 Hematologic Malignancies Detection Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF HEMATOLOGIC MALIGNANCIES DETECTION MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 HEMATOLOGIC MALIGNANCIES DETECTION MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Hematologic Malignancies Detection Sales Market Share by Type (2019-2024)
6.3 Global Hematologic Malignancies Detection Market Size Market Share by Type (2019-2024)
6.4 Global Hematologic Malignancies Detection Price by Type (2019-2024)
7 HEMATOLOGIC MALIGNANCIES DETECTION MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Hematologic Malignancies Detection Market Sales by Application (2019-2024)
7.3 Global Hematologic Malignancies Detection Market Size (M USD) by Application (2019-2024)
7.4 Global Hematologic Malignancies Detection Sales Growth Rate by Application (2019-2024)
8 HEMATOLOGIC MALIGNANCIES DETECTION MARKET SEGMENTATION BY REGION
8.1 Global Hematologic Malignancies Detection Sales by Region
8.1.1 Global Hematologic Malignancies Detection Sales by Region
8.1.2 Global Hematologic Malignancies Detection Sales Market Share by Region
8.2 North America
8.2.1 North America Hematologic Malignancies Detection Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Hematologic Malignancies Detection Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Hematologic Malignancies Detection Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Hematologic Malignancies Detection Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Hematologic Malignancies Detection Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 ArcherDx
9.1.1 ArcherDx Hematologic Malignancies Detection Basic Information
9.1.2 ArcherDx Hematologic Malignancies Detection Product Overview
9.1.3 ArcherDx Hematologic Malignancies Detection Product Market Performance
9.1.4 ArcherDx Business Overview
9.1.5 ArcherDx Hematologic Malignancies Detection SWOT Analysis
9.1.6 ArcherDx Recent Developments
9.2 Bio-Rad Laboratories
9.2.1 Bio-Rad Laboratories Hematologic Malignancies Detection Basic Information
9.2.2 Bio-Rad Laboratories Hematologic Malignancies Detection Product Overview
9.2.3 Bio-Rad Laboratories Hematologic Malignancies Detection Product Market Performance
9.2.4 Bio-Rad Laboratories Business Overview
9.2.5 Bio-Rad Laboratories Hematologic Malignancies Detection SWOT Analysis
9.2.6 Bio-Rad Laboratories Recent Developments
9.3 sysmex
9.3.1 sysmex Hematologic Malignancies Detection Basic Information
9.3.2 sysmex Hematologic Malignancies Detection Product Overview
9.3.3 sysmex Hematologic Malignancies Detection Product Market Performance
9.3.4 sysmex Hematologic Malignancies Detection SWOT Analysis
9.3.5 sysmex Business Overview
9.3.6 sysmex Recent Developments
9.4 Invitae
9.4.1 Invitae Hematologic Malignancies Detection Basic Information
9.4.2 Invitae Hematologic Malignancies Detection Product Overview
9.4.3 Invitae Hematologic Malignancies Detection Product Market Performance
9.4.4 Invitae Business Overview
9.4.5 Invitae Recent Developments
9.5 NeoGenomics Laboratories
9.5.1 NeoGenomics Laboratories Hematologic Malignancies Detection Basic Information
9.5.2 NeoGenomics Laboratories Hematologic Malignancies Detection Product Overview
9.5.3 NeoGenomics Laboratories Hematologic Malignancies Detection Product Market Performance
9.5.4 NeoGenomics Laboratories Business Overview
9.5.5 NeoGenomics Laboratories Recent Developments
9.6 Abbott Laboratories
9.6.1 Abbott Laboratories Hematologic Malignancies Detection Basic Information
9.6.2 Abbott Laboratories Hematologic Malignancies Detection Product Overview
9.6.3 Abbott Laboratories Hematologic Malignancies Detection Product Market Performance
9.6.4 Abbott Laboratories Business Overview
9.6.5 Abbott Laboratories Recent Developments
9.7 Cancer Genetics
9.7.1 Cancer Genetics Hematologic Malignancies Detection Basic Information
9.7.2 Cancer Genetics Hematologic Malignancies Detection Product Overview
9.7.3 Cancer Genetics Hematologic Malignancies Detection Product Market Performance
9.7.4 Cancer Genetics Business Overview
9.7.5 Cancer Genetics Recent Developments
9.8 Adaptive Biotechnologies Corporation
9.8.1 Adaptive Biotechnologies Corporation Hematologic Malignancies Detection Basic Information
9.8.2 Adaptive Biotechnologies Corporation Hematologic Malignancies Detection Product Overview
9.8.3 Adaptive Biotechnologies Corporation Hematologic Malignancies Detection Product Market Performance
9.8.4 Adaptive Biotechnologies Corporation Business Overview
9.8.5 Adaptive Biotechnologies Corporation Recent Developments
9.9 Asuragen
9.9.1 Asuragen Hematologic Malignancies Detection Basic Information
9.9.2 Asuragen Hematologic Malignancies Detection Product Overview
9.9.3 Asuragen Hematologic Malignancies Detection Product Market Performance
9.9.4 Asuragen Business Overview
9.9.5 Asuragen Recent Developments
9.10 Invivoscribe
9.10.1 Invivoscribe Hematologic Malignancies Detection Basic Information
9.10.2 Invivoscribe Hematologic Malignancies Detection Product Overview
9.10.3 Invivoscribe Hematologic Malignancies Detection Product Market Performance
9.10.4 Invivoscribe Business Overview
9.10.5 Invivoscribe Recent Developments
9.11 Nanjing Shihejiyin Technology
9.11.1 Nanjing Shihejiyin Technology Hematologic Malignancies Detection Basic Information
9.11.2 Nanjing Shihejiyin Technology Hematologic Malignancies Detection Product Overview
9.11.3 Nanjing Shihejiyin Technology Hematologic Malignancies Detection Product Market Performance
9.11.4 Nanjing Shihejiyin Technology Business Overview
9.11.5 Nanjing Shihejiyin Technology Recent Developments
9.12 Annaroad Gene Technology
9.12.1 Annaroad Gene Technology Hematologic Malignancies Detection Basic Information
9.12.2 Annaroad Gene Technology Hematologic Malignancies Detection Product Overview
9.12.3 Annaroad Gene Technology Hematologic Malignancies Detection Product Market Performance
9.12.4 Annaroad Gene Technology Business Overview
9.12.5 Annaroad Gene Technology Recent Developments
9.13 BGI Genomics
9.13.1 BGI Genomics Hematologic Malignancies Detection Basic Information
9.13.2 BGI Genomics Hematologic Malignancies Detection Product Overview
9.13.3 BGI Genomics Hematologic Malignancies Detection Product Market Performance
9.13.4 BGI Genomics Business Overview
9.13.5 BGI Genomics Recent Developments
10 HEMATOLOGIC MALIGNANCIES DETECTION MARKET FORECAST BY REGION
10.1 Global Hematologic Malignancies Detection Market Size Forecast
10.2 Global Hematologic Malignancies Detection Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Hematologic Malignancies Detection Market Size Forecast by Country
10.2.3 Asia Pacific Hematologic Malignancies Detection Market Size Forecast by Region
10.2.4 South America Hematologic Malignancies Detection Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Hematologic Malignancies Detection by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Hematologic Malignancies Detection Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Hematologic Malignancies Detection by Type (2025-2030)
11.1.2 Global Hematologic Malignancies Detection Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Hematologic Malignancies Detection by Type (2025-2030)
11.2 Global Hematologic Malignancies Detection Market Forecast by Application (2025-2030)
11.2.1 Global Hematologic Malignancies Detection Sales (K Units) Forecast by Application
11.2.2 Global Hematologic Malignancies Detection Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Hematologic Malignancies Detection
1.2 Key Market Segments
1.2.1 Hematologic Malignancies Detection Segment by Type
1.2.2 Hematologic Malignancies Detection Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 HEMATOLOGIC MALIGNANCIES DETECTION MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Hematologic Malignancies Detection Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Hematologic Malignancies Detection Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 HEMATOLOGIC MALIGNANCIES DETECTION MARKET COMPETITIVE LANDSCAPE
3.1 Global Hematologic Malignancies Detection Sales by Manufacturers (2019-2024)
3.2 Global Hematologic Malignancies Detection Revenue Market Share by Manufacturers (2019-2024)
3.3 Hematologic Malignancies Detection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Hematologic Malignancies Detection Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Hematologic Malignancies Detection Sales Sites, Area Served, Product Type
3.6 Hematologic Malignancies Detection Market Competitive Situation and Trends
3.6.1 Hematologic Malignancies Detection Market Concentration Rate
3.6.2 Global 5 and 10 Largest Hematologic Malignancies Detection Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 HEMATOLOGIC MALIGNANCIES DETECTION INDUSTRY CHAIN ANALYSIS
4.1 Hematologic Malignancies Detection Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF HEMATOLOGIC MALIGNANCIES DETECTION MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 HEMATOLOGIC MALIGNANCIES DETECTION MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Hematologic Malignancies Detection Sales Market Share by Type (2019-2024)
6.3 Global Hematologic Malignancies Detection Market Size Market Share by Type (2019-2024)
6.4 Global Hematologic Malignancies Detection Price by Type (2019-2024)
7 HEMATOLOGIC MALIGNANCIES DETECTION MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Hematologic Malignancies Detection Market Sales by Application (2019-2024)
7.3 Global Hematologic Malignancies Detection Market Size (M USD) by Application (2019-2024)
7.4 Global Hematologic Malignancies Detection Sales Growth Rate by Application (2019-2024)
8 HEMATOLOGIC MALIGNANCIES DETECTION MARKET SEGMENTATION BY REGION
8.1 Global Hematologic Malignancies Detection Sales by Region
8.1.1 Global Hematologic Malignancies Detection Sales by Region
8.1.2 Global Hematologic Malignancies Detection Sales Market Share by Region
8.2 North America
8.2.1 North America Hematologic Malignancies Detection Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Hematologic Malignancies Detection Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Hematologic Malignancies Detection Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Hematologic Malignancies Detection Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Hematologic Malignancies Detection Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 ArcherDx
9.1.1 ArcherDx Hematologic Malignancies Detection Basic Information
9.1.2 ArcherDx Hematologic Malignancies Detection Product Overview
9.1.3 ArcherDx Hematologic Malignancies Detection Product Market Performance
9.1.4 ArcherDx Business Overview
9.1.5 ArcherDx Hematologic Malignancies Detection SWOT Analysis
9.1.6 ArcherDx Recent Developments
9.2 Bio-Rad Laboratories
9.2.1 Bio-Rad Laboratories Hematologic Malignancies Detection Basic Information
9.2.2 Bio-Rad Laboratories Hematologic Malignancies Detection Product Overview
9.2.3 Bio-Rad Laboratories Hematologic Malignancies Detection Product Market Performance
9.2.4 Bio-Rad Laboratories Business Overview
9.2.5 Bio-Rad Laboratories Hematologic Malignancies Detection SWOT Analysis
9.2.6 Bio-Rad Laboratories Recent Developments
9.3 sysmex
9.3.1 sysmex Hematologic Malignancies Detection Basic Information
9.3.2 sysmex Hematologic Malignancies Detection Product Overview
9.3.3 sysmex Hematologic Malignancies Detection Product Market Performance
9.3.4 sysmex Hematologic Malignancies Detection SWOT Analysis
9.3.5 sysmex Business Overview
9.3.6 sysmex Recent Developments
9.4 Invitae
9.4.1 Invitae Hematologic Malignancies Detection Basic Information
9.4.2 Invitae Hematologic Malignancies Detection Product Overview
9.4.3 Invitae Hematologic Malignancies Detection Product Market Performance
9.4.4 Invitae Business Overview
9.4.5 Invitae Recent Developments
9.5 NeoGenomics Laboratories
9.5.1 NeoGenomics Laboratories Hematologic Malignancies Detection Basic Information
9.5.2 NeoGenomics Laboratories Hematologic Malignancies Detection Product Overview
9.5.3 NeoGenomics Laboratories Hematologic Malignancies Detection Product Market Performance
9.5.4 NeoGenomics Laboratories Business Overview
9.5.5 NeoGenomics Laboratories Recent Developments
9.6 Abbott Laboratories
9.6.1 Abbott Laboratories Hematologic Malignancies Detection Basic Information
9.6.2 Abbott Laboratories Hematologic Malignancies Detection Product Overview
9.6.3 Abbott Laboratories Hematologic Malignancies Detection Product Market Performance
9.6.4 Abbott Laboratories Business Overview
9.6.5 Abbott Laboratories Recent Developments
9.7 Cancer Genetics
9.7.1 Cancer Genetics Hematologic Malignancies Detection Basic Information
9.7.2 Cancer Genetics Hematologic Malignancies Detection Product Overview
9.7.3 Cancer Genetics Hematologic Malignancies Detection Product Market Performance
9.7.4 Cancer Genetics Business Overview
9.7.5 Cancer Genetics Recent Developments
9.8 Adaptive Biotechnologies Corporation
9.8.1 Adaptive Biotechnologies Corporation Hematologic Malignancies Detection Basic Information
9.8.2 Adaptive Biotechnologies Corporation Hematologic Malignancies Detection Product Overview
9.8.3 Adaptive Biotechnologies Corporation Hematologic Malignancies Detection Product Market Performance
9.8.4 Adaptive Biotechnologies Corporation Business Overview
9.8.5 Adaptive Biotechnologies Corporation Recent Developments
9.9 Asuragen
9.9.1 Asuragen Hematologic Malignancies Detection Basic Information
9.9.2 Asuragen Hematologic Malignancies Detection Product Overview
9.9.3 Asuragen Hematologic Malignancies Detection Product Market Performance
9.9.4 Asuragen Business Overview
9.9.5 Asuragen Recent Developments
9.10 Invivoscribe
9.10.1 Invivoscribe Hematologic Malignancies Detection Basic Information
9.10.2 Invivoscribe Hematologic Malignancies Detection Product Overview
9.10.3 Invivoscribe Hematologic Malignancies Detection Product Market Performance
9.10.4 Invivoscribe Business Overview
9.10.5 Invivoscribe Recent Developments
9.11 Nanjing Shihejiyin Technology
9.11.1 Nanjing Shihejiyin Technology Hematologic Malignancies Detection Basic Information
9.11.2 Nanjing Shihejiyin Technology Hematologic Malignancies Detection Product Overview
9.11.3 Nanjing Shihejiyin Technology Hematologic Malignancies Detection Product Market Performance
9.11.4 Nanjing Shihejiyin Technology Business Overview
9.11.5 Nanjing Shihejiyin Technology Recent Developments
9.12 Annaroad Gene Technology
9.12.1 Annaroad Gene Technology Hematologic Malignancies Detection Basic Information
9.12.2 Annaroad Gene Technology Hematologic Malignancies Detection Product Overview
9.12.3 Annaroad Gene Technology Hematologic Malignancies Detection Product Market Performance
9.12.4 Annaroad Gene Technology Business Overview
9.12.5 Annaroad Gene Technology Recent Developments
9.13 BGI Genomics
9.13.1 BGI Genomics Hematologic Malignancies Detection Basic Information
9.13.2 BGI Genomics Hematologic Malignancies Detection Product Overview
9.13.3 BGI Genomics Hematologic Malignancies Detection Product Market Performance
9.13.4 BGI Genomics Business Overview
9.13.5 BGI Genomics Recent Developments
10 HEMATOLOGIC MALIGNANCIES DETECTION MARKET FORECAST BY REGION
10.1 Global Hematologic Malignancies Detection Market Size Forecast
10.2 Global Hematologic Malignancies Detection Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Hematologic Malignancies Detection Market Size Forecast by Country
10.2.3 Asia Pacific Hematologic Malignancies Detection Market Size Forecast by Region
10.2.4 South America Hematologic Malignancies Detection Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Hematologic Malignancies Detection by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Hematologic Malignancies Detection Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Hematologic Malignancies Detection by Type (2025-2030)
11.1.2 Global Hematologic Malignancies Detection Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Hematologic Malignancies Detection by Type (2025-2030)
11.2 Global Hematologic Malignancies Detection Market Forecast by Application (2025-2030)
11.2.1 Global Hematologic Malignancies Detection Sales (K Units) Forecast by Application
11.2.2 Global Hematologic Malignancies Detection Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Hematologic Malignancies Detection Market Size Comparison by Region (M USD)
Table 5. Global Hematologic Malignancies Detection Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Hematologic Malignancies Detection Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Hematologic Malignancies Detection Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Hematologic Malignancies Detection Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hematologic Malignancies Detection as of 2022)
Table 10. Global Market Hematologic Malignancies Detection Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Hematologic Malignancies Detection Sales Sites and Area Served
Table 12. Manufacturers Hematologic Malignancies Detection Product Type
Table 13. Global Hematologic Malignancies Detection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Hematologic Malignancies Detection
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Hematologic Malignancies Detection Market Challenges
Table 22. Global Hematologic Malignancies Detection Sales by Type (K Units)
Table 23. Global Hematologic Malignancies Detection Market Size by Type (M USD)
Table 24. Global Hematologic Malignancies Detection Sales (K Units) by Type (2019-2024)
Table 25. Global Hematologic Malignancies Detection Sales Market Share by Type (2019-2024)
Table 26. Global Hematologic Malignancies Detection Market Size (M USD) by Type (2019-2024)
Table 27. Global Hematologic Malignancies Detection Market Size Share by Type (2019-2024)
Table 28. Global Hematologic Malignancies Detection Price (USD/Unit) by Type (2019-2024)
Table 29. Global Hematologic Malignancies Detection Sales (K Units) by Application
Table 30. Global Hematologic Malignancies Detection Market Size by Application
Table 31. Global Hematologic Malignancies Detection Sales by Application (2019-2024) & (K Units)
Table 32. Global Hematologic Malignancies Detection Sales Market Share by Application (2019-2024)
Table 33. Global Hematologic Malignancies Detection Sales by Application (2019-2024) & (M USD)
Table 34. Global Hematologic Malignancies Detection Market Share by Application (2019-2024)
Table 35. Global Hematologic Malignancies Detection Sales Growth Rate by Application (2019-2024)
Table 36. Global Hematologic Malignancies Detection Sales by Region (2019-2024) & (K Units)
Table 37. Global Hematologic Malignancies Detection Sales Market Share by Region (2019-2024)
Table 38. North America Hematologic Malignancies Detection Sales by Country (2019-2024) & (K Units)
Table 39. Europe Hematologic Malignancies Detection Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Hematologic Malignancies Detection Sales by Region (2019-2024) & (K Units)
Table 41. South America Hematologic Malignancies Detection Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Hematologic Malignancies Detection Sales by Region (2019-2024) & (K Units)
Table 43. ArcherDx Hematologic Malignancies Detection Basic Information
Table 44. ArcherDx Hematologic Malignancies Detection Product Overview
Table 45. ArcherDx Hematologic Malignancies Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. ArcherDx Business Overview
Table 47. ArcherDx Hematologic Malignancies Detection SWOT Analysis
Table 48. ArcherDx Recent Developments
Table 49. Bio-Rad Laboratories Hematologic Malignancies Detection Basic Information
Table 50. Bio-Rad Laboratories Hematologic Malignancies Detection Product Overview
Table 51. Bio-Rad Laboratories Hematologic Malignancies Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Bio-Rad Laboratories Business Overview
Table 53. Bio-Rad Laboratories Hematologic Malignancies Detection SWOT Analysis
Table 54. Bio-Rad Laboratories Recent Developments
Table 55. sysmex Hematologic Malignancies Detection Basic Information
Table 56. sysmex Hematologic Malignancies Detection Product Overview
Table 57. sysmex Hematologic Malignancies Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. sysmex Hematologic Malignancies Detection SWOT Analysis
Table 59. sysmex Business Overview
Table 60. sysmex Recent Developments
Table 61. Invitae Hematologic Malignancies Detection Basic Information
Table 62. Invitae Hematologic Malignancies Detection Product Overview
Table 63. Invitae Hematologic Malignancies Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Invitae Business Overview
Table 65. Invitae Recent Developments
Table 66. NeoGenomics Laboratories Hematologic Malignancies Detection Basic Information
Table 67. NeoGenomics Laboratories Hematologic Malignancies Detection Product Overview
Table 68. NeoGenomics Laboratories Hematologic Malignancies Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. NeoGenomics Laboratories Business Overview
Table 70. NeoGenomics Laboratories Recent Developments
Table 71. Abbott Laboratories Hematologic Malignancies Detection Basic Information
Table 72. Abbott Laboratories Hematologic Malignancies Detection Product Overview
Table 73. Abbott Laboratories Hematologic Malignancies Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Abbott Laboratories Business Overview
Table 75. Abbott Laboratories Recent Developments
Table 76. Cancer Genetics Hematologic Malignancies Detection Basic Information
Table 77. Cancer Genetics Hematologic Malignancies Detection Product Overview
Table 78. Cancer Genetics Hematologic Malignancies Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Cancer Genetics Business Overview
Table 80. Cancer Genetics Recent Developments
Table 81. Adaptive Biotechnologies Corporation Hematologic Malignancies Detection Basic Information
Table 82. Adaptive Biotechnologies Corporation Hematologic Malignancies Detection Product Overview
Table 83. Adaptive Biotechnologies Corporation Hematologic Malignancies Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Adaptive Biotechnologies Corporation Business Overview
Table 85. Adaptive Biotechnologies Corporation Recent Developments
Table 86. Asuragen Hematologic Malignancies Detection Basic Information
Table 87. Asuragen Hematologic Malignancies Detection Product Overview
Table 88. Asuragen Hematologic Malignancies Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Asuragen Business Overview
Table 90. Asuragen Recent Developments
Table 91. Invivoscribe Hematologic Malignancies Detection Basic Information
Table 92. Invivoscribe Hematologic Malignancies Detection Product Overview
Table 93. Invivoscribe Hematologic Malignancies Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Invivoscribe Business Overview
Table 95. Invivoscribe Recent Developments
Table 96. Nanjing Shihejiyin Technology Hematologic Malignancies Detection Basic Information
Table 97. Nanjing Shihejiyin Technology Hematologic Malignancies Detection Product Overview
Table 98. Nanjing Shihejiyin Technology Hematologic Malignancies Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Nanjing Shihejiyin Technology Business Overview
Table 100. Nanjing Shihejiyin Technology Recent Developments
Table 101. Annaroad Gene Technology Hematologic Malignancies Detection Basic Information
Table 102. Annaroad Gene Technology Hematologic Malignancies Detection Product Overview
Table 103. Annaroad Gene Technology Hematologic Malignancies Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Annaroad Gene Technology Business Overview
Table 105. Annaroad Gene Technology Recent Developments
Table 106. BGI Genomics Hematologic Malignancies Detection Basic Information
Table 107. BGI Genomics Hematologic Malignancies Detection Product Overview
Table 108. BGI Genomics Hematologic Malignancies Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. BGI Genomics Business Overview
Table 110. BGI Genomics Recent Developments
Table 111. Global Hematologic Malignancies Detection Sales Forecast by Region (2025-2030) & (K Units)
Table 112. Global Hematologic Malignancies Detection Market Size Forecast by Region (2025-2030) & (M USD)
Table 113. North America Hematologic Malignancies Detection Sales Forecast by Country (2025-2030) & (K Units)
Table 114. North America Hematologic Malignancies Detection Market Size Forecast by Country (2025-2030) & (M USD)
Table 115. Europe Hematologic Malignancies Detection Sales Forecast by Country (2025-2030) & (K Units)
Table 116. Europe Hematologic Malignancies Detection Market Size Forecast by Country (2025-2030) & (M USD)
Table 117. Asia Pacific Hematologic Malignancies Detection Sales Forecast by Region (2025-2030) & (K Units)
Table 118. Asia Pacific Hematologic Malignancies Detection Market Size Forecast by Region (2025-2030) & (M USD)
Table 119. South America Hematologic Malignancies Detection Sales Forecast by Country (2025-2030) & (K Units)
Table 120. South America Hematologic Malignancies Detection Market Size Forecast by Country (2025-2030) & (M USD)
Table 121. Middle East and Africa Hematologic Malignancies Detection Consumption Forecast by Country (2025-2030) & (Units)
Table 122. Middle East and Africa Hematologic Malignancies Detection Market Size Forecast by Country (2025-2030) & (M USD)
Table 123. Global Hematologic Malignancies Detection Sales Forecast by Type (2025-2030) & (K Units)
Table 124. Global Hematologic Malignancies Detection Market Size Forecast by Type (2025-2030) & (M USD)
Table 125. Global Hematologic Malignancies Detection Price Forecast by Type (2025-2030) & (USD/Unit)
Table 126. Global Hematologic Malignancies Detection Sales (K Units) Forecast by Application (2025-2030)
Table 127. Global Hematologic Malignancies Detection Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Hematologic Malignancies Detection Market Size Comparison by Region (M USD)
Table 5. Global Hematologic Malignancies Detection Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Hematologic Malignancies Detection Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Hematologic Malignancies Detection Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Hematologic Malignancies Detection Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hematologic Malignancies Detection as of 2022)
Table 10. Global Market Hematologic Malignancies Detection Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Hematologic Malignancies Detection Sales Sites and Area Served
Table 12. Manufacturers Hematologic Malignancies Detection Product Type
Table 13. Global Hematologic Malignancies Detection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Hematologic Malignancies Detection
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Hematologic Malignancies Detection Market Challenges
Table 22. Global Hematologic Malignancies Detection Sales by Type (K Units)
Table 23. Global Hematologic Malignancies Detection Market Size by Type (M USD)
Table 24. Global Hematologic Malignancies Detection Sales (K Units) by Type (2019-2024)
Table 25. Global Hematologic Malignancies Detection Sales Market Share by Type (2019-2024)
Table 26. Global Hematologic Malignancies Detection Market Size (M USD) by Type (2019-2024)
Table 27. Global Hematologic Malignancies Detection Market Size Share by Type (2019-2024)
Table 28. Global Hematologic Malignancies Detection Price (USD/Unit) by Type (2019-2024)
Table 29. Global Hematologic Malignancies Detection Sales (K Units) by Application
Table 30. Global Hematologic Malignancies Detection Market Size by Application
Table 31. Global Hematologic Malignancies Detection Sales by Application (2019-2024) & (K Units)
Table 32. Global Hematologic Malignancies Detection Sales Market Share by Application (2019-2024)
Table 33. Global Hematologic Malignancies Detection Sales by Application (2019-2024) & (M USD)
Table 34. Global Hematologic Malignancies Detection Market Share by Application (2019-2024)
Table 35. Global Hematologic Malignancies Detection Sales Growth Rate by Application (2019-2024)
Table 36. Global Hematologic Malignancies Detection Sales by Region (2019-2024) & (K Units)
Table 37. Global Hematologic Malignancies Detection Sales Market Share by Region (2019-2024)
Table 38. North America Hematologic Malignancies Detection Sales by Country (2019-2024) & (K Units)
Table 39. Europe Hematologic Malignancies Detection Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Hematologic Malignancies Detection Sales by Region (2019-2024) & (K Units)
Table 41. South America Hematologic Malignancies Detection Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Hematologic Malignancies Detection Sales by Region (2019-2024) & (K Units)
Table 43. ArcherDx Hematologic Malignancies Detection Basic Information
Table 44. ArcherDx Hematologic Malignancies Detection Product Overview
Table 45. ArcherDx Hematologic Malignancies Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. ArcherDx Business Overview
Table 47. ArcherDx Hematologic Malignancies Detection SWOT Analysis
Table 48. ArcherDx Recent Developments
Table 49. Bio-Rad Laboratories Hematologic Malignancies Detection Basic Information
Table 50. Bio-Rad Laboratories Hematologic Malignancies Detection Product Overview
Table 51. Bio-Rad Laboratories Hematologic Malignancies Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Bio-Rad Laboratories Business Overview
Table 53. Bio-Rad Laboratories Hematologic Malignancies Detection SWOT Analysis
Table 54. Bio-Rad Laboratories Recent Developments
Table 55. sysmex Hematologic Malignancies Detection Basic Information
Table 56. sysmex Hematologic Malignancies Detection Product Overview
Table 57. sysmex Hematologic Malignancies Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. sysmex Hematologic Malignancies Detection SWOT Analysis
Table 59. sysmex Business Overview
Table 60. sysmex Recent Developments
Table 61. Invitae Hematologic Malignancies Detection Basic Information
Table 62. Invitae Hematologic Malignancies Detection Product Overview
Table 63. Invitae Hematologic Malignancies Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Invitae Business Overview
Table 65. Invitae Recent Developments
Table 66. NeoGenomics Laboratories Hematologic Malignancies Detection Basic Information
Table 67. NeoGenomics Laboratories Hematologic Malignancies Detection Product Overview
Table 68. NeoGenomics Laboratories Hematologic Malignancies Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. NeoGenomics Laboratories Business Overview
Table 70. NeoGenomics Laboratories Recent Developments
Table 71. Abbott Laboratories Hematologic Malignancies Detection Basic Information
Table 72. Abbott Laboratories Hematologic Malignancies Detection Product Overview
Table 73. Abbott Laboratories Hematologic Malignancies Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Abbott Laboratories Business Overview
Table 75. Abbott Laboratories Recent Developments
Table 76. Cancer Genetics Hematologic Malignancies Detection Basic Information
Table 77. Cancer Genetics Hematologic Malignancies Detection Product Overview
Table 78. Cancer Genetics Hematologic Malignancies Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Cancer Genetics Business Overview
Table 80. Cancer Genetics Recent Developments
Table 81. Adaptive Biotechnologies Corporation Hematologic Malignancies Detection Basic Information
Table 82. Adaptive Biotechnologies Corporation Hematologic Malignancies Detection Product Overview
Table 83. Adaptive Biotechnologies Corporation Hematologic Malignancies Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Adaptive Biotechnologies Corporation Business Overview
Table 85. Adaptive Biotechnologies Corporation Recent Developments
Table 86. Asuragen Hematologic Malignancies Detection Basic Information
Table 87. Asuragen Hematologic Malignancies Detection Product Overview
Table 88. Asuragen Hematologic Malignancies Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Asuragen Business Overview
Table 90. Asuragen Recent Developments
Table 91. Invivoscribe Hematologic Malignancies Detection Basic Information
Table 92. Invivoscribe Hematologic Malignancies Detection Product Overview
Table 93. Invivoscribe Hematologic Malignancies Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Invivoscribe Business Overview
Table 95. Invivoscribe Recent Developments
Table 96. Nanjing Shihejiyin Technology Hematologic Malignancies Detection Basic Information
Table 97. Nanjing Shihejiyin Technology Hematologic Malignancies Detection Product Overview
Table 98. Nanjing Shihejiyin Technology Hematologic Malignancies Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Nanjing Shihejiyin Technology Business Overview
Table 100. Nanjing Shihejiyin Technology Recent Developments
Table 101. Annaroad Gene Technology Hematologic Malignancies Detection Basic Information
Table 102. Annaroad Gene Technology Hematologic Malignancies Detection Product Overview
Table 103. Annaroad Gene Technology Hematologic Malignancies Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Annaroad Gene Technology Business Overview
Table 105. Annaroad Gene Technology Recent Developments
Table 106. BGI Genomics Hematologic Malignancies Detection Basic Information
Table 107. BGI Genomics Hematologic Malignancies Detection Product Overview
Table 108. BGI Genomics Hematologic Malignancies Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. BGI Genomics Business Overview
Table 110. BGI Genomics Recent Developments
Table 111. Global Hematologic Malignancies Detection Sales Forecast by Region (2025-2030) & (K Units)
Table 112. Global Hematologic Malignancies Detection Market Size Forecast by Region (2025-2030) & (M USD)
Table 113. North America Hematologic Malignancies Detection Sales Forecast by Country (2025-2030) & (K Units)
Table 114. North America Hematologic Malignancies Detection Market Size Forecast by Country (2025-2030) & (M USD)
Table 115. Europe Hematologic Malignancies Detection Sales Forecast by Country (2025-2030) & (K Units)
Table 116. Europe Hematologic Malignancies Detection Market Size Forecast by Country (2025-2030) & (M USD)
Table 117. Asia Pacific Hematologic Malignancies Detection Sales Forecast by Region (2025-2030) & (K Units)
Table 118. Asia Pacific Hematologic Malignancies Detection Market Size Forecast by Region (2025-2030) & (M USD)
Table 119. South America Hematologic Malignancies Detection Sales Forecast by Country (2025-2030) & (K Units)
Table 120. South America Hematologic Malignancies Detection Market Size Forecast by Country (2025-2030) & (M USD)
Table 121. Middle East and Africa Hematologic Malignancies Detection Consumption Forecast by Country (2025-2030) & (Units)
Table 122. Middle East and Africa Hematologic Malignancies Detection Market Size Forecast by Country (2025-2030) & (M USD)
Table 123. Global Hematologic Malignancies Detection Sales Forecast by Type (2025-2030) & (K Units)
Table 124. Global Hematologic Malignancies Detection Market Size Forecast by Type (2025-2030) & (M USD)
Table 125. Global Hematologic Malignancies Detection Price Forecast by Type (2025-2030) & (USD/Unit)
Table 126. Global Hematologic Malignancies Detection Sales (K Units) Forecast by Application (2025-2030)
Table 127. Global Hematologic Malignancies Detection Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Hematologic Malignancies Detection
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Hematologic Malignancies Detection Market Size (M USD), 2019-2030
Figure 5. Global Hematologic Malignancies Detection Market Size (M USD) (2019-2030)
Figure 6. Global Hematologic Malignancies Detection Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Hematologic Malignancies Detection Market Size by Country (M USD)
Figure 11. Hematologic Malignancies Detection Sales Share by Manufacturers in 2023
Figure 12. Global Hematologic Malignancies Detection Revenue Share by Manufacturers in 2023
Figure 13. Hematologic Malignancies Detection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Hematologic Malignancies Detection Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Hematologic Malignancies Detection Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Hematologic Malignancies Detection Market Share by Type
Figure 18. Sales Market Share of Hematologic Malignancies Detection by Type (2019-2024)
Figure 19. Sales Market Share of Hematologic Malignancies Detection by Type in 2023
Figure 20. Market Size Share of Hematologic Malignancies Detection by Type (2019-2024)
Figure 21. Market Size Market Share of Hematologic Malignancies Detection by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Hematologic Malignancies Detection Market Share by Application
Figure 24. Global Hematologic Malignancies Detection Sales Market Share by Application (2019-2024)
Figure 25. Global Hematologic Malignancies Detection Sales Market Share by Application in 2023
Figure 26. Global Hematologic Malignancies Detection Market Share by Application (2019-2024)
Figure 27. Global Hematologic Malignancies Detection Market Share by Application in 2023
Figure 28. Global Hematologic Malignancies Detection Sales Growth Rate by Application (2019-2024)
Figure 29. Global Hematologic Malignancies Detection Sales Market Share by Region (2019-2024)
Figure 30. North America Hematologic Malignancies Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Hematologic Malignancies Detection Sales Market Share by Country in 2023
Figure 32. U.S. Hematologic Malignancies Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Hematologic Malignancies Detection Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Hematologic Malignancies Detection Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Hematologic Malignancies Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Hematologic Malignancies Detection Sales Market Share by Country in 2023
Figure 37. Germany Hematologic Malignancies Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Hematologic Malignancies Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Hematologic Malignancies Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Hematologic Malignancies Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Hematologic Malignancies Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Hematologic Malignancies Detection Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Hematologic Malignancies Detection Sales Market Share by Region in 2023
Figure 44. China Hematologic Malignancies Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Hematologic Malignancies Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Hematologic Malignancies Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Hematologic Malignancies Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Hematologic Malignancies Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Hematologic Malignancies Detection Sales and Growth Rate (K Units)
Figure 50. South America Hematologic Malignancies Detection Sales Market Share by Country in 2023
Figure 51. Brazil Hematologic Malignancies Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Hematologic Malignancies Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Hematologic Malignancies Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Hematologic Malignancies Detection Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Hematologic Malignancies Detection Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Hematologic Malignancies Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Hematologic Malignancies Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Hematologic Malignancies Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Hematologic Malignancies Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Hematologic Malignancies Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Hematologic Malignancies Detection Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Hematologic Malignancies Detection Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Hematologic Malignancies Detection Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Hematologic Malignancies Detection Market Share Forecast by Type (2025-2030)
Figure 65. Global Hematologic Malignancies Detection Sales Forecast by Application (2025-2030)
Figure 66. Global Hematologic Malignancies Detection Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Hematologic Malignancies Detection
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Hematologic Malignancies Detection Market Size (M USD), 2019-2030
Figure 5. Global Hematologic Malignancies Detection Market Size (M USD) (2019-2030)
Figure 6. Global Hematologic Malignancies Detection Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Hematologic Malignancies Detection Market Size by Country (M USD)
Figure 11. Hematologic Malignancies Detection Sales Share by Manufacturers in 2023
Figure 12. Global Hematologic Malignancies Detection Revenue Share by Manufacturers in 2023
Figure 13. Hematologic Malignancies Detection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Hematologic Malignancies Detection Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Hematologic Malignancies Detection Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Hematologic Malignancies Detection Market Share by Type
Figure 18. Sales Market Share of Hematologic Malignancies Detection by Type (2019-2024)
Figure 19. Sales Market Share of Hematologic Malignancies Detection by Type in 2023
Figure 20. Market Size Share of Hematologic Malignancies Detection by Type (2019-2024)
Figure 21. Market Size Market Share of Hematologic Malignancies Detection by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Hematologic Malignancies Detection Market Share by Application
Figure 24. Global Hematologic Malignancies Detection Sales Market Share by Application (2019-2024)
Figure 25. Global Hematologic Malignancies Detection Sales Market Share by Application in 2023
Figure 26. Global Hematologic Malignancies Detection Market Share by Application (2019-2024)
Figure 27. Global Hematologic Malignancies Detection Market Share by Application in 2023
Figure 28. Global Hematologic Malignancies Detection Sales Growth Rate by Application (2019-2024)
Figure 29. Global Hematologic Malignancies Detection Sales Market Share by Region (2019-2024)
Figure 30. North America Hematologic Malignancies Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Hematologic Malignancies Detection Sales Market Share by Country in 2023
Figure 32. U.S. Hematologic Malignancies Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Hematologic Malignancies Detection Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Hematologic Malignancies Detection Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Hematologic Malignancies Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Hematologic Malignancies Detection Sales Market Share by Country in 2023
Figure 37. Germany Hematologic Malignancies Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Hematologic Malignancies Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Hematologic Malignancies Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Hematologic Malignancies Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Hematologic Malignancies Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Hematologic Malignancies Detection Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Hematologic Malignancies Detection Sales Market Share by Region in 2023
Figure 44. China Hematologic Malignancies Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Hematologic Malignancies Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Hematologic Malignancies Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Hematologic Malignancies Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Hematologic Malignancies Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Hematologic Malignancies Detection Sales and Growth Rate (K Units)
Figure 50. South America Hematologic Malignancies Detection Sales Market Share by Country in 2023
Figure 51. Brazil Hematologic Malignancies Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Hematologic Malignancies Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Hematologic Malignancies Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Hematologic Malignancies Detection Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Hematologic Malignancies Detection Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Hematologic Malignancies Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Hematologic Malignancies Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Hematologic Malignancies Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Hematologic Malignancies Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Hematologic Malignancies Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Hematologic Malignancies Detection Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Hematologic Malignancies Detection Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Hematologic Malignancies Detection Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Hematologic Malignancies Detection Market Share Forecast by Type (2025-2030)
Figure 65. Global Hematologic Malignancies Detection Sales Forecast by Application (2025-2030)
Figure 66. Global Hematologic Malignancies Detection Market Share Forecast by Application (2025-2030)
